K Charles Janac

CEO K Charles Janac sold 70,000 shares at blended avg $34.91 via scheduled 10b5-1 plan; post-sale holds 8,929,071 shares.

K Charles Janac, President and CEO of Arteris, Inc., executed 2 separate sales totaling 70,000 shares for $2,443,432.56 on 2026-06-08 pursuant to a pre-arranged 10b5-1 trading plan adopted on 2025-03-05. This is a scheduled transaction, not discretionary. His prior 5 sales at AIP produced 90-day returns of +8.2%, +77.3%, +84.0%, +87.2%, and +140.5%, while his broader cross-ticker track record across 20 prior sells averaged +37.4% over 90 days—indicating his recent sales at this ticker have substantially outperformed his typical historical outcomes. The company posted $22.9M in quarterly revenue with a -$8.0M net loss, generating +22.3% annual revenue growth, yet remains unprofitable on a full-year basis. Current stock price of $33.51 sits -14.0% from the 52-week high of $38.99.

Arteris CEO K Charles Janac sells ~70K shares worth $2.2M; 92nd open-market sale in 36 months with consistent poor timing on prior exits.

K Charles Janac, Arteris's President and CEO, sold a substantial block of shares at a time when the stock is trading at its 52-week high and has rallied sharply in recent months. This is the 92nd open-market sale Janac has executed in the trailing 36 months—an extraordinary volume of dispositions with zero open-market purchases in that window. More concerning, every prior sale at this ticker has been poorly timed: the stock rose in the period following each of his five most recent exits, suggesting a consistent pattern of leaving money on the table. The company itself remains unprofitable on an annual basis with losses widening in the latest quarter, even as revenue grows. For a CEO selling aggressively near the stock's highs without any offsetting buys, the relentless and ineffective timing on his prior exits raises questions about whether this latest sale is driven by genuine conviction about valuation or simply an habitual execution of a preset divestment plan indifferent to price.

CEO JANAC K CHARLES sold 70,000 shares at $19.04; stock up +28.3% in 30d and +13.5% in 90d post-transaction.

JANAC K CHARLES sold 70,000 shares (70.0K shares) at $19.04 on 2026-04-08, reducing holdings from 9,189,071 to 9,119,071 shares. The transaction generated $1,332,786.00 in proceeds. The stock has since risen +28.3% over 30 days and +13.5% over 90 days post-sale, suggesting the timing of this sale did not precede a decline. At AIP specifically, his prior measurable sales (on 2026-03-09 and 2026-03-10) were followed by 30-day gains of +33.9% and +33.4%, respectively, indicating a consistent pattern of selling into strength. The company is unprofitable (net income $-9.0M latest quarter) despite revenue growth of +22.3% year-over-year, which creates a fundamental backdrop of losses alongside market momentum. The discretionary nature of this sale—distinct from any announced trading plan—warrants attention to whether the CEO views current valuations as appropriate for liquidation despite positive recent price momentum.

Arteris CEO Janac K Charles sold 40,000 shares across two days for $731,623.92; stock now 16.1% below 52-week high.

Janac K Charles, President and CEO, executed two separate sales totaling 40,000 shares ($731,623.92) at $18.03 and $18.35 on March 25–26, 2026. The sales reduced his holdings by 0.4% to 9,189,071 shares, a modest percentage reduction from an already substantial position. At current price of $16.51, the stock has fallen 16.1% from its 52-week high of $19.67, and his recent sales occurred near peak valuations. The company remains unprofitable (net income $-9.0M) despite strong revenue growth of 22.3%, signaling ongoing operational challenges. While his cross-ticker track record shows a 73.33% well-timed sell rate (90-day basis), his prior trades at Arteris have not yet demonstrated measurable 90-day outcomes, limiting conclusions about this insider's timing precision at this specific ticker.

CEO Janac K Charles sells 50,000 shares of AIP in 2 transactions for $714,593.40; stock down 20.6% over 90 days.

Janac K Charles, President and CEO of Arteris, Inc., executed 2 separate sales totaling 50,000 shares for $714,593.40 on 2026-03-09 and 2026-03-10, reducing his holdings by 0.5% to 9.23M shares. The blended average sale price of $14.29 comes as the stock trades at $15.62 currently, near the bottom of its 52-week range and down 20.6% from its high. Over his cross-ticker track record, the insider has demonstrated a 76.47% well-timed sell rate at the 90-day mark; however, his prior trades specifically at AIP show mixed outcomes, with 2 of 2 measurable sales well-timed at 90 days but a recent January sale that returned -10.0% over 30 days. The company is unprofitable with net income of $-9.0M against revenue of $17.4M in the latest quarter, though full-year revenue grew 22.3%, creating a backdrop of rapid growth masking operational losses.

CEO Janac K Charles sells 50,000 shares (50.0K) across 2 transactions for $759,787.93 ($759.8K); stock down -13.1% in 30 days

JANAC K CHARLES, as President and CEO, executed 2 separate sales totaling 50,000 shares (50.0K shares) for $759,787.93 ($759.8K) at a blended average price of $15.20, leaving him with 9,349,071 shares (9.35M shares) post-transaction. The stock has declined -13.1% over the 30 days following the transaction and is currently trading at $15.10, down -23.2% from its 52-week high of $19.67. Across his cross-ticker trading history, Charles's 20 prior sells have returned -15.5% on average over 90 days with a 75.00% well-timed rate; at AIP specifically, his 5 prior sells show mixed 30-day outcomes ranging from -10.0% to +33.1%, with only 1 measurable 90-day result (the November 2025 sale returned +1.3%). The company is unprofitable with net income of $-9.0M on quarterly revenue of $17.4M, though annual revenue grew +7.6% year-over-year.

CEO Janac K Charles sells 50,000 AIP shares at $16.58; stock now $17.37, up 6.6% in 30 days.

Janac K Charles sold 50,000 shares of Arteris at $16.58 on 2026-01-08, representing a 0.5% reduction in his 9.42M-share holding post-transaction. The sale price was 4.6% below the current $17.37 price, and the stock has gained 6.6% over the past 30 days, suggesting near-term upward momentum since execution. At the same ticker, Charles has completed 5 prior sells; his most recent comparable outcome (50+ days measurable) was a sale on 2025-10-08 that saw a 90-day return of +34.5%, indicating he sold ahead of gains. However, the company remains deeply unprofitable with a net loss of $-9.0M in the latest quarter against revenue of $17.4M, and Charles maintains substantial control with 9.42M shares retained. The timing pattern of this sale relative to recent positive price momentum bears watching against the backdrop of operational losses.

Arteris CEO JANAC K CHARLES sold 130,000 shares for $2,264,640.00 (2 sales); remains majority stakeholder with 9,469,071 shares post-transaction.

JANAC K CHARLES, President and CEO, executed 2 separate sales totaling 130,000 shares for $2,264,640.00 across December 5–8, 2025, at a blended average price of $17.42 per share. The current stock price of $19.19 represents an 32.5% gain over the past 30 days and a +121.6% gain over 90 days; the sales occurred below the current 52-week high. Despite divesting approximately 1.4% of his pre-transaction holdings, the CEO retains 9,469,071 shares (9.47M shares), indicating continued substantial ownership. Arteris remains unprofitable (net income of $-9.0M over the most recent full fiscal year) with revenues of $17,408,000.00 in the latest quarter, providing limited fundamental strength to anchor valuation. The timing of these sales relative to the sharp recent rally warrants investor attention, particularly given the company's ongoing losses and the concentration of CEO holdings still in place.

CEO Janac K Charles sells 40,000 AIP shares at $16.46; stock now at $18.18, up 25.6% in 30 days on path toward 52-week high.

Janac K Charles, President and CEO of Arteris Inc., sold 40,000 shares at $16.46 on 2025-12-04, reducing holdings from 9.64M to 9.60M shares. The stock has since appreciated to $18.18 (the 52-week high), gaining 25.6% over 30 days and 108.5% over 90 days—placing the transaction price 9.4% below current levels. Against his cross-ticker track record showing a 90-day well-timed rate of 100% with average 90-day returns of -26.2% after prior sales, this sale has underperformed; the stock rose after the transaction rather than falling, indicating poor timing on a cross-ticker basis. The company remains unprofitable (net income of $-9.0M in the latest quarter) despite 7.6% annual revenue growth, adding context to whether the sale reflects operational concern or mere portfolio adjustment. However, his prior five trades at AIP show 0 of 0 well-timed at the 90-day mark, and the two most recent AIP sales (2025-12-08 and 2025-12-05) occurred after this transaction, suggesting a pattern of recent liquidation in this position.

Arteris CEO JANAC K CHARLES sold 50.0K shares at $14.74 on 2025-11-10; stock at +58.4% over 90 days.

JANAC K CHARLES sold 50,000 shares of AIP at $14.74, representing a 0.5% reduction from holdings of 9.69M shares. The sale occurred amid strong recent momentum: the stock has risen 58.4% over the prior 90 days and 12.5% over the prior 30 days, trading just 3.3% below its 52-week high of $15.53. His prior five trades at AIP show mixed timing outcomes: the two 90-day measurable outcomes (both sells from August 2025) were well-timed, with the stock declining afterward. However, the company remains unprofitable, with the most recent quarter showing a net loss of $9.0M against quarterly revenue of $17.4M. The current transaction's timing relative to this profitability challenge and the stock's elevated momentum warrants observation, particularly as the outcome of his three more-recent AIP sales (from October 2025) remains unmeasurable at the 90-day horizon.